Loading...
Products:Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Tropomyosin
MSCatalog No. MS954
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-Tropomyosin 3 antibody [3D5AH3AB4]
See all Tropomyosin 3 products (4) ...
Mouse monoclonal [3D5AH3AB4] to Tropomyosin 3
IHC-P, IP, WB, ICC/IFmore details
Reacts with
Mouse, Rat, Human
Tissue / cell preparation
Human fibroblasts Mouse fibroblasts Rat fibroblasts Human Heart FFPE tissue.
Liquid
Store at +4°C.
Preservative: 0.02% Sodium azide
Constituent: HBS
Concentration information loading...
>95% by SDS-PAGE
The antibody was produced in vitro using hybridomas grown in serum-free medium, and then purified by biochemical fractionation.
Monoclonal
3D5AH3AB4
IgG2b
kappa
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Actin Binding Proteins
Signal Transduction >> Cytoskeleton / ECM >> Cytoskeleton >> Microfilaments >> Actin etc >> Tropomyosin
Western blot - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)
(enlarge)
Immunocytochemistry/ Immunofluorescence - Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)
(enlarge)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)
(enlarge)
Our Abpromise guarantee covers the use of ab113692 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
IHC-P: Use a concentration of 10 µg/ml.
IP: Use at an assay dependent concentration.
WB: Use a concentration of 1 µg/ml. Detects a band of approximately 32 kDa (predicted molecular weight: 32 kDa).
ICC/IF: Use a concentration of 2 µg/ml.
Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments.
Defects in TPM3 are the cause of nemaline myopathy type 1 (NEM1) [MIM:609284]. A form of nemaline myopathy with autosomal dominant or recessive inheritance. Nemaline myopathies are muscular disorders characterized by muscle weakness of varying severity and onset, and abnormal thread-or rod-like structures in muscle fibers on histologic examination. Autosomal dominant nemaline myopathy type 1 is characterized by a moderate phenotype with onset between birth and early second decade of life. Weakness is diffuse and symmetric with slow progression often with need for a wheelchair in adulthood. The autosomal recessive form has onset at birth with moderate-to-severe hypotonia and diffuse weakness. In the most severe cases, death can occur before 2 years. Less severe cases have delayed major motor milestones, and these patients may walk, but often need a wheelchair before 10 years.
Defects in TPM3 are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=A chromosomal aberration involving TPM3 is found in thyroid papillary carcinomas. A rearrangement with NTRK1 generates the TRK fusion transcript by fusing the amino end of isoform 2 of TPM3 to the 3'-end of NTRK1.
Belongs to the tropomyosin family.
The molecule is in a coiled coil structure that is formed by 2 polypeptide chains. The sequence exhibits a prominent seven-residues periodicity.
Cytoplasm > cytoskeleton.
Target information above from: UniProt accessionP06753
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)
![Western blot - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)](/ps/datasheet/images/113/ab113692/Tropomyosin-3-Primary-antibodies-ab113692-5.jpg)
All lanes : Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692) at 1 µg/ml
Lane 1 : HepG2 (human)
Lane 2 : HDFN (human)
Lane 3 : H9C2 (rat)
Lane 4 : H4IIE (rat)
Lane 5 : MEF (mouse)
Lysates/proteins at 20 µg per lane.
developed using the ECL technique
Performed under reducing conditions.
Predicted band size : 32 kDa
Immunocytochemistry/ Immunofluorescence - Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)
![Immunocytochemistry/ Immunofluorescence - Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)](/ps/datasheet/images/113/ab113692/Tropomyosin-3-Primary-antibodies-ab113692-3.jpg)
ab113692 stained human fibroblast (HDFn) cells, rat cardiomyocytes (H9C2 cells) and mouse embryo fibroblast (MEF) cells. The cells were paraformaldehyde fixed (4%, 20 min) and Triton X-100 permeabilized (0.1%, 15 min). The cells were incubated with the antibody (3D5AH3AB4,5 µg/ml) for 2h at room temperature or over night at 4°C. The secondary antibody was (red) Alexa Fluor® 594 goat anti-mouse IgG2b (H+L) at a 1/1000 dilution for 1h. 10% Goat serum was used as the blocking agent for all blocking steps. The target protein locates to cytoskeleton.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)](/ps/datasheet/images/113/ab113692/Tropomyosin-3-Primary-antibodies-ab113692-6.jpg)
IHC image of Tropomyosin 3 staining in Human heart formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab113692, 10µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
ab113692 has not yet been referenced specifically in any publications.
Publishing research using ab113692? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Immunocytochemistry/ Immunofluorescence - Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)](/ps/datasheet/images/113/ab113692/Tropomyosin-3-Primary-antibodies-ab113692-3.jpg)
ab113692 stained human fibroblast (HDFn) cells, rat cardiomyocytes (H9C2 cells) and mouse embryo fibroblast (MEF) cells. The cells were paraformaldehyde fixed (4%, 20 min) and Triton X-100 permeabilized (0.1%, 15 min). The cells were incubated with the antibody (3D5AH3AB4,5 µg/ml) for 2h at room temperature or over night at 4°C. The secondary antibody was (red) Alexa Fluor® 594 goat anti-mouse IgG2b (H+L) at a 1/1000 dilution for 1h. 10% Goat serum was used as the blocking agent for all blocking steps. The target protein locates to cytoskeleton.
![Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Tropomyosin 3 antibody [3D5AH3AB4] (ab113692)](/ps/datasheet/images/113/ab113692/Tropomyosin-3-Primary-antibodies-ab113692-6.jpg)
IHC image of Tropomyosin 3 staining in Human heart formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab113692, 10µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
